Quality key factors
Factor
Value
Sales Growth (5y)
3.40%
EBIT Growth (5y)
-196.95%
EBIT to Interest (avg)
-253.03
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.68
EV to EBIT
-6.78
EV to EBITDA
-6.87
EV to Capital Employed
5.24
EV to Sales
1763.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-77.29%
ROE (Latest)
-31.16%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
Bearish
Bullish
Bollinger Bands
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
2What is working for the Company
NET PROFIT(HY)
Higher at HKD -118.68 MM
-4What is not working for the Company
INTEREST(HY)
At HKD 2.32 MM has Grown at 5,429.56%
Here's what is working for VISEN Pharmaceuticals
Net Profit
Higher at HKD -118.68 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Here's what is not working for VISEN Pharmaceuticals
Interest
At HKD 2.32 MM has Grown at 5,429.56%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Footer loading






